• Client Login
Ozmosi
  • Services
    • BEAM Clinical Trial Data
    • GCT Global Clinical Trials
    • PRYZM Pharma Product Database
    • KRYSTL Industry Scan Reporting
    • LENZ Company Pipeline Summary
    • Specialized Consulting
    • Approved Pharmaceutical Products in Use
  • About Us
  • Case Studies
  • Newsroom
  • Conference Info
  • Contact Us
Select Page
The Obesity Drug Pipeline in 2026: Emerging Targets, Companies and Clinical Readouts

The Obesity Drug Pipeline in 2026: Emerging Targets, Companies and Clinical Readouts

Aug 17, 2026 | Industry Trends, Market Scan, New Technology

The Obesity Drug Pipeline in 2026 Obesity drug development is expanding rapidly beyond the first generation of GLP-1 therapies. More than 1 billion people worldwide were living with obesity in 2022, including approximately 890 million adults. The clinical and...
Why Clinical Trial Data Belongs in Every Pharma Valuation Model

Why Clinical Trial Data Belongs in Every Pharma Valuation Model

Aug 4, 2026 | Business, Clinical Trial Trends, Industry Trends

Financial statements show how much pharmaceutical companies spend. Clinical trial data reveals whether that investment is building future pipeline value. Introduction Financial statements tell us how much pharmaceutical companies spend. Clinical trial registries tell...
OZMOSI Announces Strategic Partnership with Planview to Advance AI-Driven Planning in Pharmaceutical R&D

OZMOSI Announces Strategic Partnership with Planview to Advance AI-Driven Planning in Pharmaceutical R&D

May 13, 2026 | Business

By combining structured clinical intelligence with AI-driven portfolio planning, the partnership gives pharmaceutical teams a faster, clearer way to make high-stakes R&D decisions SPRING LAKE HEIGHTS, N.J., April 23, 2026 / PRNewswire / — OZMOSI, a leading...
7 Small-Cap Biotech Companies to Watch at AACR in April

7 Small-Cap Biotech Companies to Watch at AACR in April

Oct 23, 2025 | Industry Trends, New Technology

We anticipate scientific reviews and clinical trial updates from 40 companies on nearly 80 oncology development programs at the upcoming American Association for Cancer Research (AACR) Annual Meeting, which will take place April 5-10 in San Diego. The information...
Covid-19 Clinical Trials and Where to Get Treated

Covid-19 Clinical Trials and Where to Get Treated

Nov 27, 2020 | COVID-19, Disease Area Trends

We all know the basics for fighting the COVID-19 virus, like washing our hands and staying socially distant from one another, but what about future vaccines and treatments? There is a lot of talk right now about different companies making progress and potential...

Recent Posts

  • The Obesity Drug Pipeline in 2026: Emerging Targets, Companies and Clinical ReadoutsAugust 17, 2026
  • Why Clinical Trial Data Belongs in Every Pharma Valuation ModelAugust 4, 2026
  • OZMOSI Announces Strategic Partnership with Planview to Advance AI-Driven Planning in Pharmaceutical R&DMay 13, 2026
  • Pharmaceutical Portfolio Strategy in the AI Era: Why External Intelligence MattersApril 29, 2026
  • Why AI Stalls in Pharmaceutical R&D Operations (and How to Fix It)March 31, 2026
  • Who is Winning in Innovation and How are They Balancing Risk?February 28, 2026
  • Home
  • About Us
  • Services
  • Case Studies
  • Newsroom
  • Contact Us
  • Facebook
  • X
OZMOSI© 2026 | All Rights Reserved | Site by Webtyde